The new formulation targets internal and external parasites, expanding the BRAVECTO® portfolio RAHWAY, N.J., November 26, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for […]
Vaccine can now be administered intramuscularly or through subcutaneous injection as well as at the same time as BOVILIS® CRYPTIUM® Subcutaneous injections are generally well-tolerated by animals, can minimize pain and distress, and improve meat quality[i] RAHWAY, N.J., October 15, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States […]
RAHWAY, N.J., March 14, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBILIS MULTRIVA™ RT+IBm+ND+Gm+REOm+EDS vaccine to […]